Higher consumption of ultra-processed foods may be linked to an increased risk of developing and dying from cancer, an Imperial-led study suggests.
Cell therapy engineered to eliminate established tumors, train immune system to prevent cancer recurrence
A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers. The drug stalled the growth of tumors in the five people in the trial with neuroendocrine cancers and reduced tumor size in two of those patients. It also showed some therapeutic activity against sarcomas, scientists and clinicians report in the British Journal of Cancer.
University of Saskatchewan (USask) researchers have developed a new method of killing brain cancer cells while preserving the delicate tissue around it. The technique also has a remarkable side-benefit: making chemotherapy treatment of brain cancer suddenly possible.
Liver cancer is one of the most deadly types of cancer. The team led by Prof. Michael N. Hall from the Biozentrum of the University of Basel has now uncovered how a healthy liver cell turns into a tumor cell. Comprehensive metabolic changes convert mature liver cells into immature progenitor cells. These cells proliferate rapidly and tumors develop.